All News

European lawmakers are set to sign off on an EU-wide law on advanced therapies. But an attempt to limit the law has sparked a last-minute lobbying drive from the industry to try to avert the exclusion of stem cell therapies.

It is time to drop euphemisms like DNA medicines and gene-based medicines. Gene therapy, says Nuala Moran, has made it through to the commercial mainstream.

The UK’s Particle Physics and Astronomy Research Council has announced a further £30 million to analyse the expected deluge of data from CERN’s new particle accelerator near Geneva.

The European Commission is proposing a compromise to break decades of deadlock in the effort to create a European Union-wide patent.

Universities in the UK plan to show off their wares to bioscience and pharmaceutical companies.

Gene therapy is poised to make a commercial breakthrough after Oxford BioMedica agreed global rights for a cancer treatment with Sanofi-Aventis, in a deal with a headline value of €518 million.